{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:10:09Z","timestamp":1790475009393,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.diagmicrobio.2013.09.016","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T17:41:13Z","timestamp":1385487673000},"page":"222-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and Cameroon"],"prefix":"10.1016","volume":"79","author":[{"given":"Pedro Miguel","family":"dos Santos Abrantes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole P.","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene Wilma Joyce","family":"Africa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0005","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/dkq023","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe","volume":"65","author":"Adriaenssens","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1590\/S0037-86822006000100020","article-title":"Utilization of tomato juice agar (V8 agar) in the presumptive identification of Candida dubliniensis","volume":"39","author":"Alves","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0732-8893(02)00440-6","article-title":"Antifungal susceptibility of South African oral yeast isolates from HIV\/AIDS patients and healthy individuals","volume":"44","author":"Blignaut","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1128\/JCM.40.3.826-836.2002","article-title":"Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa","volume":"40","author":"Blignaut","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.09.016_bb0025","series-title":"Document M44-A2. Method for antifungal disk diffusion susceptibility testing of yeasts. Approved Guideline","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1590\/S1413-86702002000300003","article-title":"Fluconazole susceptibility of Brazilian Candida isolates assessed by a disk diffusion method","volume":"6","author":"Colombo","year":"2002","journal-title":"Braz J Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S1020-49892008000200014","article-title":"Regional laboratory network for surveillance of invasive fungal infections and antifungal susceptibility in Latin America","volume":"23","author":"Cuenca-Estrella","year":"2008","journal-title":"Rev Panam Salud Publica"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1130-1406(08)70002-0","article-title":"Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibility","volume":"25","author":"Eraso","year":"2008","journal-title":"Rev Iberoam Micol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0045","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1128\/AAC.44.6.1585-1587.2000","volume":"44","author":"Goldman","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.09.016_bb0050","unstructured":"Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents. CDC, NIH and IDS report 2009; 58(RR04): 1-198."},{"key":"10.1016\/j.diagmicrobio.2013.09.016_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2180-8-135","article-title":"Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis","volume":"8","author":"Hamza","year":"2008","journal-title":"BMC Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbrc.2008.06.093","article-title":"RTA2, a novel gene involved in azole resistance in Candida albicans","volume":"373","author":"Jia","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0065","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1128\/JCM.42.10.4796-4798.2004","article-title":"Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans","volume":"42","author":"Khan","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1439-0507.2008.01542.x","article-title":"Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina","volume":"52","author":"Luque","year":"2009","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0075","first-page":"23","article-title":"Antifungal resistance: an emerging problem in Mexico","volume":"144","author":"Manzano-Gayosso","year":"2008","journal-title":"Gac Med Mex"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/40.4.511","article-title":"Fluconazole disc diffusion testing for the routine laboratory","volume":"40","author":"May","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5923\/j.microbiology.20120205.04","article-title":"Strengths and limitations of different chromogenic media for the identification of Candida species","volume":"2","author":"Messeir","year":"2012","journal-title":"J Microbiol Res"},{"issue":"Spec Issue B","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0090","first-page":"837","article-title":"Antifungal susceptibility of oral Candida isolates from HIV\/AIDS patients","volume":"85","author":"Molepo","year":"2006","journal-title":"J Dent Res"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0095","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/jac\/46.2.338","article-title":"Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis","volume":"46","author":"Muller","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.09.016_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2334-13-82","article-title":"Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia","volume":"13","author":"Mulu","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0105","first-page":"4","article-title":"In vitro antifungal susceptibility patterns of Candida albicans from HIV and AIDS patients attending the Nylon Health District Hospital in Douala, Cameroon","volume":"2","author":"Njunda","year":"2012","journal-title":"J Public Health Africa"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0110","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/JCM.38.4.1563-1568.2000","article-title":"Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations","volume":"38","author":"Pelletier","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0115","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JCM.02161-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.diagmicrobio.2012.05.008","article-title":"Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values","volume":"73","author":"Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0125","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.44.3.819-826.2006","article-title":"Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/JCM.01398-10","article-title":"Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0135","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/JCM.36.7.2093-2095.1998","article-title":"Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans","volume":"36","author":"Pinjon","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"16","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0140","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1089\/088922299309900","article-title":"Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: a critical reassessment","volume":"15","author":"Powderly","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.diagmicrobio.2013.09.016_bb0145","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/00365540802275853","article-title":"Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole","volume":"40","author":"Rautemaa","year":"2008","journal-title":"Scand J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2013.09.016_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijantimicag.2006.03.012","article-title":"Antifungal drug resistance: limited data, dramatic impact?","volume":"27","author":"Rogers","year":"2006","journal-title":"Int J Antimicrob Agents"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931300624X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931300624X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T16:47:41Z","timestamp":1597078061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288931300624X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S073288931300624X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.09.016","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and Cameroon","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}